Russell & Rubinsteins Pathology Of Tumors Of The Nervous System6E 2 Vol Set 1998 Edition at Meripustak

Russell & Rubinsteins Pathology Of Tumors Of The Nervous System6E 2 Vol Set 1998 Edition

Books from same Author: BIGNER D.D.

Books from same Publisher: SP ARNOLD

Related Category: Author List / Publisher List


  • Retail Price: ₹ 42574/- [ 20.00% off ]

    Seller Price: ₹ 34060

Sold By: T K Pandey      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 20.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 20.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock
General Information  
Author(s)BIGNER D.D.
PublisherSP ARNOLD
Edition6th New edition
ISBN9780340581131
Pages1424
BindingHardback
LanguageEnglish
Publish YearJune 1998

Description

SP ARNOLD Russell & Rubinsteins Pathology Of Tumors Of The Nervous System6E 2 Vol Set 1998 Edition by BIGNER D.D.

This 6th edition represents a comprehensive review of the pathology and biology of tumours which affect the nervous system. Substantially enlarged and wholly revised to reflect the remarkable progress in the field this book will serve as an encylopaedic guide to the growth of brain tumours for both practising and training neuropathologists.Most significantly this edition now features eight new chapters on basic aspects of brain tumour genetics epidemiology growth factors invasion and metastasis neurocarcinogens and cellular and molecular immunology. The diagnostic aspects of central nervous system tumours have been completely updated with three new chapters on cerebrospinal fluid cytopathology flow cytometry and DNA ploidy analysis and immunohistochemistry and complete revisions of the chapters on parasellar neoplasms and peripheral nervous system neoplasms.Now in two volumes the text has also been expanded to incorporate recent advances in the understanding of factors involved in the genesis and progression of primary malignant tumors in neuroimaging and in tumour classifications (including the recently revised WHO classification system) with emphasis placed on those factors identified with prognostic significance.